Amicus Therapeutics (AM6.F) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.15
-0.11
-0.08
-0.05

Details

Expected EPS
-0.05028620097
Actual EPS
-0.0458005
Surprise EPS
0
Surprise Percent
+8.92%

Description

Amicus Therapeutics (AM6.F) has reported earnings of -0.0458005 per share for Q3 2024.

0 Comments

Share your thoughts